However, although altered protein glycosylation in the brains of AD patients has been indicated by several studies [72,101,102], it remains unknown whether AD-causing PS mutations, including those of PS2, affect protein glycosylation events. This evidence concerns the gene PSEN2 and Alzheimer disease.